Research Article of International Journal of Stem Cell Research
Evaluation of Effects Baccharis Dracunculifolia (Green Propolis) in Embryonic Development
Silva, P.A.A1, Pedrosa, J.V.C2, Silva, W.M.V2, Santos, D.F2, Narciso, M.L3, Silva, F.F.L3, Silva, J.M.B4, Silva, E.V5, Anjos, F.B.R6.
Master in Pathology of Universidade Federal de Pernambuco1, Students of Universidade Federal de Pernambuco2, Biology of Universidade Federal de Pernambuco3, Biotechnology and Bioprocess Engineer4, Universidade Federal de Pernambuco5, Professor of Universidade Federal de Pernambuco6
Propolis is a resinous substance made by bees from various plant fragments. Bees add salivary enzymes to their composition and this partially digested material is mixed with wax and used to make the beehive (MARCUCCI, 1995; BANKOVA et al., 2000). She may exhibit varied coloration, such as dark brown, greenish tones and reddish brown.
A recently discovered type in Brazil is the red propolis, originating from the mangrove plant, Dalbergia ecastophyllum (SILVA et al., 2008). However, the one that has gained international prominence is the one produced from the plant Baccharis dracunculifolia (Asteraceae), the green propolis (MARCUCCI, BANKOVA, 1999). Although many studies have been carried out to evaluate the characteristics of several propolis samples, none of them confirmed or allowed any relationship between the chemical composition of propolis and its therapeutic efficacy (BANKOVA, 2005a).
Due to the importance of the biological properties of green propolis, in addition to its wide use. This study aimed to add existing data on the use of propolis during pregnancy, especially warning about the possible risks of using green propolis (Baccharis dracunculifolia) during this period.
Keywords: Theory vortex gravitation, cosmology and cosmogony. Celestial mechanics
How to cite this article:
Silva, P.A.A, Pedrosa, J.V.C, Silva, W.M.V, Santos, D.F, Narciso, M.L, Silva, F.F.L, Silva, J.M.B, Silva, E.V5, Anjos, F.B.R.Evaluation of Effects Baccharis Dracunculifolia (Green Propolis) in Embryonic Development. International Journal of Stem Cell Research. 2018, 1:1
1. Bankova, V. Chemical diversity of propolis and the problem of standardization. Journal of Ethnopharmacology, Lausanne, v. 100, p. 114-117, 2005a.
2. Bankova, V. Recent trends and important developments in propolis research. Evidence-based Complementary and Alternative Medicine, Oxford, v. 2, n. 1, p. 29-31, 2005b.
3. Bankova, V.; Castro, S.; Marcucci, M.C. Propolis: recent advances in chemistry and plant origin. Apidologie, Versailles, v. 30, p. 3-15, 2000.
4. Behrman, R.E.; Keilgman, R.M.; Arvin, A.M. (eds): Nelson Textbook of Pediatrics, 15 th ed. Philadelphia, WB Saunders, 1996.
5. Carlson, M. Embriologia humana e biologia do desenvolvimento. 2ª ed. 2016, p.380.
6. Champetier, J.; yver, R.; tomasella, T. Functional anatomy of the liver of the human fetus: applications to ultrasonography. SurgRadiol Anat., v. 11, n. 53, 1989.
7. Dias, P.F.; Siqueira-Junior, J.M.; Vendrusco, T.J.; Neiva, M.; Maraschin, A.; Gagliardi, R.M. Antiangiogenic and antitumoral properties of polysaccharide isolated from the seaweed Sargassum stenophyllum. Cancer Chemother Pharmacol. 2005.
8. Dvorak, H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med, v. 315, n.26, p.1650-1659, 1986.
9. Folkman, J.; Shing, Y. Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol, v.313, p.355-364, 1992.
10. Levinsohn, E.M.; Hootnick, D.R.; Packard, D.S. Consistent arterial abnormalities associated with avariety of congenital. Malformation softhelower limb. Invest Radiol, v. 26, n. 364, 1991.
11. Marik J. et al. Long-circulating liposomes radiolabeled with [18F] fluorodipalmitin ([18F]FDP). Nucl. Med. Biol. 34, 165–171 (2007).
12. Moore, K.L.; Persaud, T.V.N. Embriologia Clínica. 7ª ed. Rio de Janeiro: Guanabara Koogan, 2008. p. 632.
13. Murugesan S, Mousa SA, O’Connor J, Lincoln DW, 2nd, Linhardt RJ. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett. 2007;581: 1157–1160.
14. Sahni A, Khorana AA, Baggs RB, Peng H, Francis CW. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Blood. 2006; 107: 126–131.
15. Stolzmann P. et al. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease. Radiographics. 31, 1255–1269 (2011).
16. Tufan AC, Satiroglu-Tufan NL. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. Curr Cancer Drug Targets. 2005; 5:249–266.
17. Wolpert, L. The triumph of the Embryo. Oxford, Oxford University Press, 1991.
This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.